Acromegaly: pathogenesis, diagnosis, and management.

Fleseriu, Maria; Langlois, Fabienne; Lim, Dawn Shao Ting; Varlamov, Elena V; Melmed, Shlomo

Fleseriu, Maria; Langlois, Fabienne; Lim, Dawn Shao Ting; Varlamov, Elena V; Melmed, Shlomo.

Afiliação

Fleseriu M; Department of Medicine (Division of Endocrinology, Diabetes and Clinical Nutrition) and Department of Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, OR, USA. Electronic address: fleseriu@ohsu.edu.
Langlois F; Division of Endocrinology, Department of Medicine, Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie-Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
Lim DST; Department of Endocrinology, Singapore General Hospital, Singapore.
Varlamov EV; Department of Medicine (Division of Endocrinology, Diabetes and Clinical Nutrition) and Department of Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, OR, USA.
Melmed S; Department of Medicine and Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Lancet Diabetes Endocrinol ; 10(11): 804-826, 2022 11.

Article em En | MEDLINE | ID: mdl-36209758

Assuntos

Acromegalia; Adenoma; Hormônio do Crescimento Humano; Humanos; Acromegalia/diagnóstico; Acromegalia/epidemiologia; Acromegalia/etiologia; Fator de Crescimento Insulin-Like I/metabolismo; Qualidade de Vida; Hormônio do Crescimento; Adenoma/diagnóstico; Adenoma/epidemiologia; Adenoma/terapia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acromegalia / Adenoma / Hormônio do Crescimento Humano Tipo de estudo: Diagnostic_studies / Etiology_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google